Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Steinberg

Showing results (631-640 of 692) with videos related to

Pageof 70
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical ProstatectomyJohn Nikitas, Clayton P Smith, Wesley R Armstrong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy PlanningJeremie Calais, Johannes Czernin, Minsong Cao, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2021
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated PatientsRitchell van Dams, Naomi Y Jiang, Donald B Fuller, et al.
European Urology|December 14, 2020
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)Luca F Valle, Eric J Lehrer, Daniela Markovic, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2023
Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical TrialsJohn Nikitas, Wee Loon Ong, Nathalie Carrier, et al.
Journal of Open Source Software|October 7, 2024
SMITE: Single Molecule Imaging Toolbox Extraordinaire (MATLAB)David J Schodt, Michael J Wester, Mohamadreza Fazel, et al.
JAMA Oncology|October 17, 2018
Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysisAmar U Kishan, Xiaoyan Wang, Wendy Seiferheld, et al.
Cancer|November 3, 2015
Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancerAaron A Laviana, Annette M Ilg, Darlene Veruttipong, et al.
American Journal of Clinical Oncology|April 18, 2018
Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue SarcomasJoseph Daniel Pennington, Fritz C Eilber, Frederick R Eilber, et al.
The Journal of Urology|December 11, 2019
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder CancerRyan L Steinberg, Lewis J Thomas, Nathan Brooks, et al.
Pageof 70

Showing results (631-640 of 692) with videos related to

Sort By:
Pageof 70
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical ProstatectomyJohn Nikitas, Clayton P Smith, Wesley R Armstrong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy PlanningJeremie Calais, Johannes Czernin, Minsong Cao, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2021
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated PatientsRitchell van Dams, Naomi Y Jiang, Donald B Fuller, et al.
European Urology|December 14, 2020
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)Luca F Valle, Eric J Lehrer, Daniela Markovic, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2023
Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical TrialsJohn Nikitas, Wee Loon Ong, Nathalie Carrier, et al.
Journal of Open Source Software|October 7, 2024
SMITE: Single Molecule Imaging Toolbox Extraordinaire (MATLAB)David J Schodt, Michael J Wester, Mohamadreza Fazel, et al.
JAMA Oncology|October 17, 2018
Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysisAmar U Kishan, Xiaoyan Wang, Wendy Seiferheld, et al.
Cancer|November 3, 2015
Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancerAaron A Laviana, Annette M Ilg, Darlene Veruttipong, et al.
American Journal of Clinical Oncology|April 18, 2018
Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue SarcomasJoseph Daniel Pennington, Fritz C Eilber, Frederick R Eilber, et al.
The Journal of Urology|December 11, 2019
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder CancerRyan L Steinberg, Lewis J Thomas, Nathan Brooks, et al.
Pageof 70